menu
    • menu

    Find Clopidogrel manufacturers, exporters & distributors on PharmaCompass

    NEW Prospects: 47
    Clopidogrel Bisulfate

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Clopidogrel

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass

    Synopsis

    Related ProductsRelated Products

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 120202-66-6, Clopidogrel sulfate, Clopidogrel hydrogen sulfate, Iscover, Plavix, Clopidogrel bisulphate
    Molecular Formula
    C16H18ClNO6S2
    Molecular Weight
    419.9  g/mol
    InChI Key
    FDEODCTUSIWGLK-RSAXXLAASA-N
    FDA UNII
    08I79HTP27
    Clopidogrel
    A ticlopidine analog and platelet purinergic P2Y receptor antagonist that inhibits adenosine diphosphate-mediated PLATELET AGGREGATION. It is used to prevent THROMBOEMBOLISM in patients with ARTERIAL OCCLUSIVE DISEASES; MYOCARDIAL INFARCTION; STROKE; or ATRIAL FIBRILLATION.
    1 2D Structure

    Clopidogrel

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate;sulfuric acid
    2.1.2 InChI
    InChI=1S/C16H16ClNO2S.H2O4S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;1-5(2,3)4/h2-5,7,9,15H,6,8,10H2,1H3;(H2,1,2,3,4)/t15-;/m0./s1
    2.1.3 InChI Key
    FDEODCTUSIWGLK-RSAXXLAASA-N
    2.1.4 Canonical SMILES
    COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3.OS(=O)(=O)O
    2.1.5 Isomeric SMILES
    COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3.OS(=O)(=O)O
    2.2 Other Identifiers
    2.2.1 UNII
    08I79HTP27
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Clopidogrel

    2. Clopidogrel Besilate

    3. Clopidogrel Besylate

    4. Clopidogrel Hydrochloride

    5. Clopidogrel Mepha

    6. Clopidogrel Napadisilate

    7. Clopidogrel Sandoz

    8. Clopidogrel, (+)(s)-isomer

    9. Clopidogrel-mepha

    10. Iscover

    11. Pcr 4099

    12. Pcr-4099

    13. Plavix

    14. Sc 25989c

    15. Sc 25990c

    16. Sr 25989

    2.3.2 Depositor-Supplied Synonyms

    1. 120202-66-6

    2. Clopidogrel Sulfate

    3. Clopidogrel Hydrogen Sulfate

    4. Iscover

    5. Plavix

    6. Clopidogrel Bisulphate

    7. Clopidogrel Hemisulfate

    8. (s)-methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4h)-yl)acetate Sulfate

    9. Clopidogrel Hydrogen Sulphate

    10. Clopidogrel Bms

    11. Clopidogrel Sulphate

    12. Sr 25990c

    13. Clopidogrel (hydrogen Sulfate)

    14. Isocover

    15. Pidogrel

    16. Clopidogrel-bgr

    17. Clopidogrel-bms

    18. Clopidogrel Teva

    19. Clopidogrel Zentiva

    20. Clopidogrel (plavix)

    21. Clopidogrel Ratiopharm

    22. Sr-25990c

    23. S-(+)-clopidogrel Hydrogen Sulfate

    24. Clopidogrel (as Bisulfate)

    25. (s)-(+)-clopidogrel Sulfate

    26. 08i79htp27

    27. 120202-66-6 (sulfate)

    28. Pm-103

    29. Methyl (s)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4h)-yl)acetate Sulfate

    30. 144077-07-6

    31. Myogrel

    32. Clopidogrel Hydrogensulfate

    33. Plavix (tn)

    34. Dsstox_cid_26024

    35. Dsstox_rid_81297

    36. Dsstox_gsid_46024

    37. Plavitor

    38. Osvix

    39. Chebi:3759

    40. Chembl1083385

    41. Methyl (2s)-2-(2-chlorophenyl)-2-(6,7-dihydro-4h-thieno[3,2-c]pyridin-5-yl)acetate Sulfate

    42. Methyl (2s)-2-(2-chlorophenyl)-2-(6,7-dihydro-4h-thieno[3,2-c]pyridin-5-yl)acetate;sulfuric Acid

    43. Sulfuric Acid Methyl (2s)-2-(2-chlorophenyl)-2-{4h,5h,6h,7h-thieno[3,2-c]pyridin-5-yl}acetate

    44. Clopidogrel Bisulfate [usan]

    45. Cas-135046-48-9

    46. Unii-08i79htp27

    47. R-(-)-clopidogrel Hydrogen Sulfate

    48. Clopidogrel Bisulfate [usan:usp]

    49. Isocover (tn)

    50. Clopidogrel Bisolfato

    51. (s)-(+)-clopidogrel Hydrogen Sulfate

    52. Bisulfato De Clopidogrel

    53. Bissulfato De Clopidogrel

    54. Ncgc00159321-02

    55. (+)-clopidogrel Bisulfate

    56. (+) Clopidogrel Bisulfate

    57. Methyl Alphas-(2-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4h)-acetate Sulfate (1:1)

    58. Clopidogrel Bisulfate (usp)

    59. Clopidogrel Sulfate (jp17)

    60. Schembl33556

    61. Clopidogrel Hydrogen Sulphate

    62. Spectrum1503710

    63. Mdco-157

    64. (+)-clopidogrel Hydrogen Sulfate

    65. Clopidogrel Sulfate [jan]

    66. Dtxsid601016080

    67. Hms1922g16

    68. Hms2093i13

    69. Hms3884g15

    70. Pharmakon1600-01503710

    71. Amy40591

    72. Clopidogrel Sulfate Tablets (jp17)

    73. Tox21_111570

    74. Ccg-39568

    75. Clopidogrel Bisulfate [vandf]

    76. Mfcd00876395

    77. Nsc758613

    78. S1415

    79. Clopidogrel Bisulfate [mart.]

    80. Akos015900408

    81. Clopidogrel Bisulfate [usp-rs]

    82. Clopidogrel Bisulfate [who-dd]

    83. Tox21_111570_1

    84. Ac-2135

    85. Cs-1882

    86. Dv-7314

    87. Ks-1045

    88. S65c842

    89. Clopidogrel (as Hydrogen Sulfate)

    90. Clopidogrel Hydrogen Sulfate [mi]

    91. Ncgc00163329-03

    92. 111ge004

    93. Bc164326

    94. Hy-17459

    95. Methyl (+)-(s)-alpha-(o-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4h)-acetate, Sulfate (1:1)

    96. Thieno(3,2-c)pyridine-5(4h)-acetic Acid, 6,7-dihydro-alpha-(2-chlorophenyl)-, Methyl Ester, (s)-, Sulfate

    97. Thieno(3,2-c)pyridine-5(4h)-acetic Acid, Alpha-(2-chlorophenyl)-6,7-dihydro-, Methyl Ester, (alphas)-, Sulfate (1:1)

    98. Thieno(3,2-c)pyridine-5(4h)-acetic Acid, Alpha-(2-chlorophenyl)-6,7-dihydro-, Methyl Ester, (s)-, Sulfate (1:1)

    99. Thieno[3,2-c]pyridine-5(4h)-acetic Acid,a-(2-chlorophenyl)-6,7-dihydro-, Methyl Ester, (as)-, Sulfate (1:1)

    100. Clopidogrel Bisulfate [orange Book]

    101. Clopidogrel Bisulfate [usp Monograph]

    102. Sw219457-1

    103. Clopidogrel Hydrogen Sulfate [ema Epar]

    104. D00769

    105. Duocover Component Clopidogrel Bisulfate

    106. Duoplavin Component Clopidogrel Bisulfate

    107. Clopidogrel Hydrogen Sulphate [ema Epar]

    108. Clopidogrel Bisulfate Component Of Duocover

    109. Clopidogrel Bisulfate Component Of Duoplavin

    110. Clopidogrel Hydrogen Sulfate [ep Monograph]

    111. Sr-05000002068

    112. J-006637

    113. Sr-05000002068-1

    114. (+)-clopidogrel1r(-)camphor-10-sulphonic Acid Salt

    115. (s)-(+)-clopidogrel Hydrogensulfate, >=98% (hplc)

    116. Q27888063

    117. Z1550648767

    118. (s)-(+)-clopidogrel Bisulfate;(s)-(+)-clopidogrel Hydrogen Sulfate

    119. Clopidogrel Bisulfate, United States Pharmacopeia (usp) Reference Standard

    120. Clopidogrel Hydrogen Sulfate, European Pharmacopoeia (ep) Reference Standard

    121. Clopidogrel/acetylsalicyclic Acid Teva Component Clopidogrel Bisulfate

    122. (s)-(+)-methyl (2-chlorophenyl)(6,7-dihydro-4h-thieno(3,2-c)pyrid-5-yl)acetate Bisulfate

    123. Clopidogrel Bisulfate Component Of Clopidogrel/acetylsalicyclic Acid Teva

    124. Clopidogrel Bisulfate, Pharmaceutical Secondary Standard; Certified Reference Material

    125. Clopidogrel For System Suitability, European Pharmacopoeia (ep) Reference Standard

    126. Methyl(s)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4h)-yl)acetatesulfate

    127. (s)-(+)-methyl 2-(4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-yl)-2-(2-chlorophenyl)acetate Hydrogen Sulfate

    128. (s)-(2-chloro-phenyl)-(6,7-dihydro-4h-thieno[3,2-c]pyridin-5-yl)-acetic Acid Methyl Ester Sulfuric Acid Salt

    129. (s)-methyl-(2-chloro-phenyl)-(6,7-dihydro-4h-thieno[3,2-c]pyridin-5-yl)-acetate H2so4

    130. Methyl (+)-(s)-.alpha.-(o-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4h)-acetate, Sulfate (1:1)

    131. Methyl (+)-(s)-.alpha.-(o-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4h)-acetate, Sulphate (1:1)

    132. Methyl (2s)-2-(2-chlorophenyl)-2-{4h,5h,6h,7h-thieno[3,2-c]pyridin-5-yl}acetate; Sulfuric Acid

    133. Methyl (s)-(+)-2-(2-chlorophenyl)-2-[6,7-dihydro-4h-thieno[3,2-c]pyridin-5-yl]acetate Sulfate

    134. Thieno(3,2-c)pyridine-5(4h)-acetic Acid, .alpha.-(2-chlorophenyl)-6,7-dihydro-, Methyl Ester, (s)-, Sulfate (1:1)

    135. Thieno(3,2-c)pyridine-5(4h)-acetic Acid, .alpha.-(2-chlorophenyl)-6,7-dihydro-, Methyl Ester, (s)-, Sulphate (1:1)

    2.4 Create Date
    2005-06-24
    3 Chemical and Physical Properties
    Molecular Weight 419.9 g/mol
    Molecular Formula C16H18ClNO6S2
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count8
    Rotatable Bond Count4
    Exact Mass419.0264073 g/mol
    Monoisotopic Mass419.0264073 g/mol
    Topological Polar Surface Area141 Ų
    Heavy Atom Count26
    Formal Charge0
    Complexity463
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 4  
    Drug NameClopidogrel bisulfate
    Drug LabelClopidogrel bisulfate USP is a thienopyridine class inhibitor of P2Y12 ADP platelet receptors. Chemically it is methyl (+)-(S)--(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)acetate sulfate (1:1). The molecular formula of clopidogrel bisul...
    Active IngredientClopidogrel bisulfate
    Dosage FormTablet
    RouteOral
    Strengtheq 300mg base; eq 75mg base
    Market StatusPrescription
    CompanyWockhardt; Mylan Pharms; Actavis Elizabeth; Teva Pharms; Macleods Pharms; Mutual Pharm; Gate Pharms; Teva; Apotex; Accord Hlthcare; Sciegen Pharms; Aurobindo Pharma; Torrent Pharms; Zydus Pharms Usa; Dr Reddys Labs; Sun Pharma Global; Roxane

    2 of 4  
    Drug NamePlavix
    PubMed HealthClopidogrel (By mouth)
    Drug ClassesPlatelet Aggregation Inhibitor
    Drug LabelPlavix (clopidogrel bisulfate) is a thienopyridine class inhibitor of P2Y12 ADP platelet receptors. Chemically it is methyl (+)-(S)--(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate sulfate (1:1). The empirical formula of clopidogrel...
    Active IngredientClopidogrel bisulfate
    Dosage FormTablet
    RouteOral
    Strengtheq 75mg base; eq 300mg base
    Market StatusPrescription
    CompanySanofi Aventis Us

    3 of 4  
    Drug NameClopidogrel bisulfate
    Drug LabelClopidogrel bisulfate USP is a thienopyridine class inhibitor of P2Y12 ADP platelet receptors. Chemically it is methyl (+)-(S)--(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)acetate sulfate (1:1). The molecular formula of clopidogrel bisul...
    Active IngredientClopidogrel bisulfate
    Dosage FormTablet
    RouteOral
    Strengtheq 300mg base; eq 75mg base
    Market StatusPrescription
    CompanyWockhardt; Mylan Pharms; Actavis Elizabeth; Teva Pharms; Macleods Pharms; Mutual Pharm; Gate Pharms; Teva; Apotex; Accord Hlthcare; Sciegen Pharms; Aurobindo Pharma; Torrent Pharms; Zydus Pharms Usa; Dr Reddys Labs; Sun Pharma Global; Roxane

    4 of 4  
    Drug NamePlavix
    PubMed HealthClopidogrel (By mouth)
    Drug ClassesPlatelet Aggregation Inhibitor
    Drug LabelPlavix (clopidogrel bisulfate) is a thienopyridine class inhibitor of P2Y12 ADP platelet receptors. Chemically it is methyl (+)-(S)--(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate sulfate (1:1). The empirical formula of clopidogrel...
    Active IngredientClopidogrel bisulfate
    Dosage FormTablet
    RouteOral
    Strengtheq 75mg base; eq 300mg base
    Market StatusPrescription
    CompanySanofi Aventis Us

    4.2 Drug Indication

    Secondary prevention of atherothrombotic events Clopidogrel is indicated in:

    - Adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

    - Adult patients suffering from acute coronary syndrome:

    - Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA).

    - ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy.

    Prevention of atherothrombotic and thromboembolic events in atrial fibrillation

    In adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with Vitamin K antagonists (VKA) and who have a low bleeding risk, clopidogrel is indicated in combination with ASA for the prevention of atherothrombotic and thromboembolic events, including stroke.

    Secondary prevention of atherothrombotic events

    Clopidogrel is indicated in:

    - Adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

    - Adult patients suffering from acute coronary syndrome:

    - Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA).

    - ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy.

    - Prevention of atherothrombotic and thromboembolic events in atrial fibrillation

    In adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with Vitamin K antagonists (VKA) and who have a low bleeding risk, clopidogrel is indicated in combination with ASA for the prevention of atherothrombotic and thromboembolic events, including stroke.

    * Secondary prevention of atherothrombotic events:

    Clopidogrel is indicated in:

    - Adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

    - Adult patients suffering from acute coronary syndrome:

    - Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA).

    - ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy.

    In patients with moderate to high-risk Transient Ischemic Attack (TIA) or minor Ischemic Stroke (IS)

    Clopidogrel in combination with ASA is indicated in:

    - Adult patients with moderate to high-risk TIA (ABCD2 score 4) or minor IS (NIHSS 3) within 24 hours of either the TIA or IS event.

    * Prevention of atherothrombotic and thromboembolic events in atrial fibrillation:

    In adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with Vitamin K antagonists (VKA) and who have a low bleeding risk, clopidogrel is indicated in combination with ASA for the prevention of atherothrombotic and thromboembolic events, including stroke.

    Prevention of atherothrombotic events Clopidogrel is indicated in:

    Adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

    Prevention Secondary prevention of atherothrombotic events Clopidogrel is indicated in:

    - Adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

    - Adult patients suffering from acute coronary syndrome:

    - Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA).

    - ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy.

    - Prevention of atherothrombotic and thromboembolic events in atrial fibrillation:

    - In adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with Vitamin K antagonists (VKA) and who have a low bleeding risk, clopidogrel is indicated in combination with ASA for the prevention of atherothrombotic and thromboembolic events, including stroke.

    * Secondary prevention of atherothrombotic events:

    Clopidogrel is indicated in:

    - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from seven days until less than six months) or established peripheral arterial disease;

    - adult patients suffering from acute coronary syndrome:

    - non-ST-segment-elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA);

    - ST-segment-elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy.

    - In patients with moderate to high-risk Transient Ischemic Attack (TIA) or minor Ischemic Stroke (IS)

    Clopidogrel in combination with ASA is indicated in:

    - Adult patients with moderate to high-risk TIA (ABCD2 score 4) or minor IS (NIHSS 3) within 24 hours of either the TIA or IS event.

    * Prevention of atherothrombotic and thromboembolic events in atrial fibrillation:

    In adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin-K antagonists and who have a low bleeding risk, clopidogrel is indicated in combination with ASA for the prevention of atherothrombotic and thromboembolic events, including stroke.

    Clopidogrel is indicated in adults for the prevention of atherothrombotic events in:

    - patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

    For further information please refer to section 5. 1.

    Clopidogrel is indicated in adults for the prevention of atherothrombotic events in:

    - Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

    - Patients suffering from acute coronary syndrome:

    Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA).

    ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy.

    5 Pharmacology and Biochemistry
    5.1 MeSH Pharmacological Classification

    Platelet Aggregation Inhibitors

    Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)

    Purinergic P2Y Receptor Antagonists

    Compounds that bind to and block the stimulation of PURINERGIC P2Y RECEPTORS. Included under this heading are antagonists for specific P2Y receptor subtypes. (See all compounds classified as Purinergic P2Y Receptor Antagonists.)

    5.2 FDA Pharmacological Classification
    5.2.1 Pharmacological Classes
    Decreased Platelet Aggregation [PE]; P2Y12 Platelet Inhibitor [EPC]; P2Y12 Receptor Antagonists [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]
    5.3 ATC Code

    B01AC04

    B01AC04

    B01AC04

    B01AC03

    B01AC04

    B01AC04

    B01AC04

    B01AC04

    API SUPPLIERS

    read-more
    read-more

    01

    Dr. Reddy's Laboratories

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI North America
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-01-30

    Pay. Date : 2013-01-04

    DMF Number : 16090

    Submission : 2002-08-07

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2021-052 - Rev 01

    Issue Date : 2023-02-20

    Type : Chemical

    Substance Number : 2531

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 304MF10059

    Registrant's Address : 8-2-337, Road No. 3, Banjara Hills, Hyderabad 500 034, TELANGANA, INDIA

    Initial Date of Registration : 2022-03-30

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2025-06-20

    Valid Till : 2028-07-07

    Written Confirmation Number : WC-0039

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 71796-027

    Start Marketing Date : 2020-12-30

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF arrow-down
    ✖

    Registrant Name : Agerson Bio Co., Ltd.

    Registration Date : 2025-02-05

    Registration Number : 20110225-129-H-88-15(17)

    Manufacturer Name : Dr. Reddy's Laboratories Limited

    Manufacturer Address : CTO - Unit-I, Plot Nos. 137,138,145 & 146, SV Co-Op, Industrial Estate, Bollaram Village, Jinnaram Mandal, Sangareddy District, Telangana - 502 325, INDIA

     VMF ASMF, CD... arrow-down
    ✖
    Available Reg Filing : ASMF, CDMF
    AUDIT arrow-down
    Dr Reddy Company Banner

    02

    IOL Chemicals and Pharmaceuticals

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI North America
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothIOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 36534

    Submission : 2022-06-16

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2019-006 - Rev 02

    Issue Date : 2026-01-27

    Type : Chemical

    Substance Number : 2531

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2025-02-27

    Valid Till : 2028-03-17

    Written Confirmation Number : WC-0004

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 49716-329

    Start Marketing Date : 2023-10-15

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF arrow-down
    ✖

    Registrant Name : Aging Life Science Co., Ltd.

    Registration Date : 2025-02-28

    Registration Number : 20250228-129-H-431-62

    Manufacturer Name : IOL Chemicals and Pharmaceuticals Limited

    Manufacturer Address : Village: Fatebgarh Channa, Mansa Road (Trident Complex) Barnala-148101(Punjab), India

     VMF RU arrow-down
    ✖
    Available Reg Filing : RU
    AUDIT arrow-down
    IOL Chemicals

    03

    EUROAPI

    France

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    TIDES USA
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 226MF10008

    Registrant's Address : 82 Avenue Raspail 94250 Gentilly (FRANCE)

    Initial Date of Registration : 2014-01-08

    Latest Date of Registration :

    EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Handok Co., Ltd.

    Registration Date : 2010-11-30

    Registration Number : 20101130-129-H-39-07

    Manufacturer Name : Sanofi Winthrop Industrie

    Manufacturer Address : 45 Chemin De Météline, Sisteron, 04200, France

     VMF ASMF arrow-down
    ✖
    Available Reg Filing : ASMF
    AUDIT arrow-down
    EUROAPI Compnay Banner

    04

    Sanofi

    France

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AMWC Asia-TDAC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 12439

    Submission : 1997-03-06

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2024-307 - Rev 00

    Issue Date : 2026-04-08

    Type : Chemical

    Substance Number : 2531

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
    Sanofi Company Banner

    05

    LGM Pharma

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI North America
    Booth #730
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    LGM Pharma CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Metrochem API Private Limited

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Vietnam Medi-Pharm Expo
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 34334

    Submission : 2020-02-05

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2020-093 - Rev 01

    Issue Date : 2024-06-20

    Type : Chemical

    Substance Number : 2531

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 304MF10071

    Registrant's Address : Flat No. 302, Bhanu Enclave, Sunder Nagar, Erragadda, Hyderabad - 500038, Telangana, India

    Initial Date of Registration : 2022-05-12

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2024-04-03

    Valid Till : 2027-01-21

    Written Confirmation Number : WC-0493

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 42765-004

    Start Marketing Date : 2020-01-17

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : BULK INGREDIENT

     KDMF arrow-down
    ✖

    Registrant Name : Boryeong Co., Ltd.

    Registration Date : 2025-03-07

    Registration Number : 20250307-129-H-435-63

    Manufacturer Name : Metrochem API Pvt Ltd, Unit- IV

    Manufacturer Address : Plot No. 34B, 40B & 60B, JN Pharma City, Thanam (V) Parawada (M), Anakapalli District – 531 021, Andhra Pradesh, India.

     VMF Others AUDIT arrow-down
    Metrochem

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Jai Radhe Sales

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AMWC Asia-TDAC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Jai Radhe Sales

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Virupaksha Organics

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Chemspec Europe
    Booth #7E108
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothWith Virupaksha, you get a quality product with on-time delivery.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Virupaksha

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    HRV Pharma

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AMWC Asia-TDAC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF AU, MX, ... arrow-down
    ✖
    Available Reg Filing : AU, MX, ASMF
    AUDIT
    HRV Global Life Sciences

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Octavius Pharma Pvt. Ltd

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AMWC Asia-TDAC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothOctavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Octavius Pharma

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    JDMF

    read-more
    read-moreread-more

    01

    Dr. Reddy's Laboratories Ltd.

    India
    arrow
    CPhI North America
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    CLOPIDOGREL SULPHATE FORM-Ⅱ

    Registration Number : 303MF10053

    Registrant's Address : 8-2-337, Road No. 3, Banjara Hills, Hyderabad 500 034, TELANGANA, INDIA

    Initial Date of Registration : 2021-03-26

    Latest Date of Registration : 2021-03-26

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Dr. Reddy's Laboratories Ltd.

    India
    arrow
    CPhI North America
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    CLOPIDOGREL SULFATE FORM-Ⅰ

    Registration Number : 304MF10059

    Registrant's Address : 8-2-337, Road No. 3, Banjara Hills, Hyderabad 500 034, TELANGANA, INDIA

    Initial Date of Registration : 2022-03-30

    Latest Date of Registration : 2022-03-30

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    SANOFI WINTHROP INDUSTRIE

    France
    arrow
    TIDES USA
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel sulfate

    Registration Number : 226MF10008

    Registrant's Address : 82 Avenue Raspail 94250 Gentilly (FRANCE)

    Initial Date of Registration : 2014-01-08

    Latest Date of Registration : 2015-04-09

    EUROAPI Compnay Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Metrochem API Pvt. Ltd.

    India
    arrow
    Vietnam Medi-Pharm Expo
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel sulfate

    Registration Number : 304MF10071

    Registrant's Address : Flat No. 302, Bhanu Enclave, Sunder Nagar, Erragadda, Hyderabad - 500038, Telangana, ...

    Initial Date of Registration : 2022-05-12

    Latest Date of Registration : 2023-09-06

    Metrochem

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Daito Co., Ltd.

    Japan
    Arvo
    Not Confirmed
    arrow

    Daito Co., Ltd.

    Japan
    arrow
    Arvo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel sulfate

    Registration Number : 226MF10034

    Registrant's Address : 326 Yokamachi, Toyama City, Toyama Prefecture

    Initial Date of Registration : 2014-02-05

    Latest Date of Registration : 2024-05-15

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    KYUNG DONG PHARM. C.O. , LTD.

    South Korea
    Arvo
    Not Confirmed
    arrow

    KYUNG DONG PHARM. C.O. , LTD.

    South Korea
    arrow
    Arvo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel sulfate

    Registration Number : 301MF10039

    Registrant's Address : 9FL, KyungDong Pharm Bldg, 1926, Nambusunhwan-ro, Gwanak-gu, Seoul, Republic of Korea

    Initial Date of Registration : 2019-08-09

    Latest Date of Registration : 2019-08-09

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    KYUNG DONG PHARM. C.O. , LTD.

    South Korea
    Arvo
    Not Confirmed
    arrow

    KYUNG DONG PHARM. C.O. , LTD.

    South Korea
    arrow
    Arvo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel sulfate

    Registration Number : 302MF10107

    Registrant's Address : 9FL, KyungDong Pharm Bldg, 1926, Nambusunhwan-ro, Gwanak-gu, Seoul, Republic of Korea

    Initial Date of Registration : 2020-09-01

    Latest Date of Registration : 2020-09-01

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    KYUNG DONG PHARM. C.O. , LTD.

    South Korea
    Arvo
    Not Confirmed
    arrow

    KYUNG DONG PHARM. C.O. , LTD.

    South Korea
    arrow
    Arvo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel sulfate

    Registration Number : 306MF10113

    Registrant's Address : 3F SMART-K Bldg. B, 26, Gwacheon-daero 7-gil, Gwacheon-si, Gyeonggi-do, Republic of K...

    Initial Date of Registration : 2024-08-22

    Latest Date of Registration : 2024-08-22

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Osaka Synthetic Organic Chemistry R...

    Japan
    Arvo
    Not Confirmed
    arrow

    Osaka Synthetic Organic Chemistry R...

    Japan
    arrow
    Arvo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel sulfate (for manufacturing purposes only)

    Registration Number : 226MF10032

    Registrant's Address : 1-1-2 Nishinomiyahama, Nishinomiya City, Hyogo Prefecture

    Initial Date of Registration : 2014-02-05

    Latest Date of Registration : 2025-09-17

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Samjin Pharmaceutical Co. , Ltd.　

    South Korea
    Arvo
    Not Confirmed
    arrow

    Samjin Pharmaceutical Co. , Ltd.　

    South Korea
    arrow
    Arvo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel sulfate

    Registration Number : 228MF10164

    Registrant's Address : 121 Wausan-ro, Mapo-gu, Seoul, Korea

    Initial Date of Registration : 2016-08-19

    Latest Date of Registration : 2016-08-19

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    KDMF

    read-more
    read-moreread-more

    01

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI North America
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel hydrogen sulfate

    Registrant Name : EQ Bio Co., Ltd.

    Registration Date : 2024-11-05

    Registration Number : 20110225-129-H-88-15(16)

    Manufacturer Name : Dr. Reddy's Laboratories Lim...

    Manufacturer Address : CTO-Unit I, Plot No. 137, 138, 145 & 146, Sri Venkateswara Co-operative industrial es...

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI North America
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel hydrogen sulfate

    Registrant Name : JL Bio Co., Ltd.

    Registration Date : 2022-06-17

    Registration Number : 20210715-129-H-390-56(1)

    Manufacturer Name : Dr. Reddy's Laboratories Ltd...

    Manufacturer Address : CTO-Unit-V, Peddadevulapally Village, Tripuraram Mandal, Nalgonda District, Telangana...

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI North America
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel sulfate

    Registrant Name : IMCD Korea Co., Ltd.

    Registration Date : 2017-12-08

    Registration Number : 20110225-129-H-88-15(12)

    Manufacturer Name : Dr. Reddy's Laboratories Lim...

    Manufacturer Address : CTO-Unit-I, Plot Nos. 137,138,145 & 146, SV Co-Op, Industrial Estate, Bollaram Villag...

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI North America
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel hydrogen sulfate

    Registrant Name : Agerson Bio Co., Ltd.

    Registration Date : 2025-02-05

    Registration Number : 20110225-129-H-88-15(17)

    Manufacturer Name : Dr. Reddy's Laboratories Lim...

    Manufacturer Address : CTO - Unit-I, Plot Nos. 137,138,145 & 146, SV Co-Op, Industrial Estate, Bollaram Vill...

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI North America
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel sulfate

    Registrant Name : Daewoong Bio Co., Ltd.

    Registration Date : 2012-05-18

    Registration Number : 20110225-129-H-88-15(9)

    Manufacturer Name : Dr. Reddy's Laboratories Lim...

    Manufacturer Address : 137/138,146, Sri Venkateswara Co-operative Industrial estate, Bollaram,_x000D_ Jinnar...

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI North America
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel hydrogen sulfate

    Registrant Name : Farmist Co., Ltd.

    Registration Date : 2022-09-19

    Registration Number : 20210715-129-H-390-56(2)

    Manufacturer Name : Dr. Reddy's Laboratories Ltd...

    Manufacturer Address : CTO-Unit-V, Peddadevulapally Village, Tripuraram Mandal, Nalgonda District, Telangana...

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI North America
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel hydrogen sulfate

    Registrant Name : Teragen Etex Co., Ltd.

    Registration Date : 2022-09-19

    Registration Number : 20210715-129-H-390-56(3)

    Manufacturer Name : Dr. Reddy's Laboratories Ltd...

    Manufacturer Address : CTO-Unit-V, Peddadevulapally Village, Tripuraram Mandal, Nalgonda District, Telangana...

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI North America
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel hydrogen sulfate

    Registrant Name : MPK Korea Co., Ltd.

    Registration Date : 2020-03-18

    Registration Number : 20110225-129-H-88-15(14)

    Manufacturer Name : Dr. Reddy's Laboratories Lim...

    Manufacturer Address : CTO - Unit-I, Plot Nos. 137,138,145 & 146, SV Co-Op, Industrial Estate, Bollaram Vill...

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI North America
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel sulfate

    Registrant Name : Husid Co., Ltd.

    Registration Date : 2023-02-13

    Registration Number : 20110225-129-H-88-15(15)

    Manufacturer Name : Dr. Reddy's Laboratories Lim...

    Manufacturer Address : CTO - Unit-I, Plot Nos. 137,138,145 & 146, SV Co-Op, Industrial Estate, Bollaram Vill...

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI North America
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel sulfate

    Registrant Name : Pharma Solution Co., Ltd.

    Registration Date : 2018-03-09

    Registration Number : 20110225-129-H-88-15(13)

    Manufacturer Name : Dr.Reddy's Laboratories Limi...

    Manufacturer Address : CTO - Unit-I, Plot Nos. 137,138,145 & 146, SV Co-Op, Industrial Estate, Bollaram Vill...

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Listed Suppliers

    read-more
    read-more

    01

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI North America
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel

    About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...

    Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK & are inspected by international regulatory authorities on a regular basis. Its facilities are supplemented by formulation facilities that provide a wide range of dosage forms. Product(s) under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale
    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    IOL Chemicals and Pharmaceuticals

    India
    arrow
    CPhI North America
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothIOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel Bisulfate

    About the Company : IOL Chemicals and Pharmaceuticals Limited, with over three decades of experience, is an innovation-driven company specializing in bulk drugs, intermediates, and specialty chemicals...

    IOL Chemicals and Pharmaceuticals Limited, with over three decades of experience, is an innovation-driven company specializing in bulk drugs, intermediates, and specialty chemicals. As an API-based manufacturer, it offers economies of scale and cost advantages with substantial production capacity. Its API portfolio covers pain management, anti-diabetic, anti-hypertensive, and anti-convulsant categories. IOL Chemicals is backward-integrated, producing all intermediates and key starting materials for ibuprofen. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    IOL Chemicals

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    EUROAPI

    France
    arrow
    TIDES USA
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel Hydrogen Sulfate

    About the Company : EUROAPI focuses on reinventing active ingredient solutions to sustainably meet the needs of customers and patients worldwide. The company is a leading API player with a portfolio o...

    EUROAPI focuses on reinventing active ingredient solutions to sustainably meet the needs of customers and patients worldwide. The company is a leading API player with a portfolio of around 200 products, covering a wide range of technologies and innovative molecules through CDMO activities. Supported by 3,650 employees, strong R&D capabilities, and six manufacturing sites in Europe, EUROAPI delivers high-quality API manufacturing to customers in more than 80 countries. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    EUROAPI Compnay Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    LGM Pharma

    U.S.A
    arrow
    CPhI North America
    Booth #730
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel

    About the Company : LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product ...

    LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product CDMO, offering formulation, analytical method development and testing, regulatory support, and commercial manufacturing. Supported by a network of over 220 accredited cGMP manufacturing partners and more than 100,000 sq. ft. of FDA-inspected cGMP manufacturing and warehouse space, LGM delivers secure, end-to-end solutions across multiple dosage forms. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    LGM Pharma CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Metrochem API Private Limited

    India
    arrow
    Vietnam Medi-Pharm Expo
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel

    About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...

    Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product groups and has been approved by ISO 9001-2015, USFDA, WHO GMP, Cofepris & Japanese authorities. Metrochem’s in-depth industry knowledge, & hi-tech & advanced infrastructure, helps it provide quality products to its customers. Note: None of the products will be supplied to the countries where this could conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer
    Metrochem

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Jai Radhe Sales

    India
    arrow
    Arvo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel

    About the Company : Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and r...

    Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and regulatory support, and strives for global standards. Known for quality and affordability, it has established a niche through innovative methods and exports to nearly every continent. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Jai Radhe Sales

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Virupaksha Organics

    India
    arrow
    Chemspec Europe
    Booth #7E108
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothWith Virupaksha, you get a quality product with on-time delivery.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel

    About the Company : Virupaksha Organics, founded in 2003, is a leading manufacturer of APIs and intermediates. Its FDA-audited, ISO-certified facilities in Kazipally and Pashamylaram produce high-qual...

    Virupaksha Organics, founded in 2003, is a leading manufacturer of APIs and intermediates. Its FDA-audited, ISO-certified facilities in Kazipally and Pashamylaram produce high-quality products. With 300+ customers in 100 countries, Virupaksha has built a strong global presence and a trusted reputation for reliability. Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer
    Virupaksha

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    HRV Pharma

    India
    arrow
    Arvo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel

    About the Company : HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing...

    HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing, manufacturing, and supply services to support partners entering new markets worldwide. HRV Pharma works closely with major pharma and food additive companies and represents over 30 Indian drugmakers, primarily serving Europe, the US, and the Middle East. Headquartered in India, it operates offices in the US, Switzerland, Dubai, Lithuania, and Turkey. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    HRV Global Life Sciences

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Octavius Pharma Pvt. Ltd

    India
    arrow
    Arvo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothOctavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel

    About the Company : Octavius Pharma is a global leader in Directly Compressible Granules with over 45 years of experience in formulation development, manufacturing, and commercialization. Its portfoli...

    Octavius Pharma is a global leader in Directly Compressible Granules with over 45 years of experience in formulation development, manufacturing, and commercialization. Its portfolio includes DC granules, herbal and food supplements, APIs, and finished formulations such as tablets, capsules, syrups, and ointments. With WHO-GMP certification and a DSIR-certified R&D center, the company ensures quality and innovation, exporting to LATAM, the Middle East, Africa, Asia, and CIS regions, and offering formulation and marketing support. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Octavius Pharma

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Tenatra Exports

    India
    arrow
    Arvo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothTenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clopidogrel

    About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...

    Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opportunities grew, it was felt that the proprietorship firm had outlived its usefulness and that it needed a corporate structure. So, Tenatra Exports Private Limited was incorporated in 2002. Since then, the company has come a long way, gaining valuable experience and knowledge in the fields of chemicals and pharmaceuticals in India. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Tenatra

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    DRUG PRODUCT COMPOSITIONS

    Do you need Business Intel? Ask us

    DOSAGE - TABLET;ORAL - EQ 300MG BASE

    USFDA APPLICATION NUMBER - 20839

    read-more

    DOSAGE - TABLET;ORAL - EQ 75MG BASE

    USFDA APPLICATION NUMBER - 20839

    read-more

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Fillers, Diluents & Binders

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Granulation

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Topical

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Empty Capsules

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    Vegetarian Capsules

    read-more
    read-more

    Surfactant & Foaming Agents

    read-more
    read-more

    Coloring Agents

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    APIs

    read-more
    read-more
    saudiarabiapng-1555324364png-1605701218.png
    Clopidogrel Bisulfate (1 MT) API needed in U.A.E [ENA25331]
    A company that deals in the supply and distribution of APIs, intermediates & excipients is looking for suppliers of Clopidogrel Bisulfate (1 MT) API for commercial purposes. The suppliers must support this enquiry with CoA.
    17 Feb 2026

    Reply

    17 Feb 2026

    Reply text-arrow

    Reply Comment (5)

    17 Feb 2026

    india-flag.png
    USP Grade Clopidogrel Bisulphate API needed in India [ENA24824]
    A company that focuses on the manufacturing of active pharmaceutical ingredients and various finished dosage formulations is looking for suppliers of USP Grade Clopidogrel Bisulphate (14.4 MT/ annum) API for commercial purposes. The suppliers must support this enquiry with CoA.
    16 Dec 2025

    Reply

    16 Dec 2025

    Reply text-arrow

    Reply Comment (5)

    16 Dec 2025

    Egypt.png
    Clopidogrel Bisulfate (10 kg) API needed in Egypt [ENA24796]
    A company that focuses on the distribution of various pharmaceutical and cosmetic products is looking for suppliers of Clopidogrel Bisulfate (10 kg) API for commercial purposes. The suppliers must support this enquiry with GMP & CoA.
    12 Dec 2025

    Reply

    12 Dec 2025

    Reply text-arrow

    Reply Comment (2)

    12 Dec 2025

    india-flag.png
    Clopidogrel + Aspirin Pellets needed in India [ENA23386]
    A company that focuses strongly on the development and manufacturing of products in various specialties, including antibiotics, anti-allergic, anti-inflammatory, & respiratory, is looking for suppliers of Clopidogrel + Aspirin Pellets for commercial purposes. The required quantity is 50 kg. The suppliers must support this enquiry with CoA.
    01 Jul 2025

    Reply

    01 Jul 2025

    Reply text-arrow

    Reply Comment (1)

    01 Jul 2025

    india-flag.png
    Clopidogrel (75 mg) Pellets needed in India [ENA23013]
    A company that focuses on the manufacturing and marketing of various third-party and own-branded formulations is looking for suppliers of Clopidogrel (75 mg) Pellets for commercial purposes. The required quantity is 1 lakh units. The suppliers must support this enquiry with CoA.
    21 May 2025

    Reply

    21 May 2025

    Reply text-arrow

    Reply Comment (1)

    21 May 2025

    unitedkingdom_new.png
    Clopidogrel (100 kg) API needed in United Kingdom [ENA22426]
    A company based in the United Kingdom that deals in various pharmaceutical products like injections, syrups & hygiene products is looking for suppliers of Clopidogrel (100 kg) API for commercial purposes. The suppliers must support this enquiry with CEP & CoA.
    24 Mar 2025

    Reply

    24 Mar 2025

    Reply text-arrow

    Reply Comment (5)

    24 Mar 2025

    india-flag.png
    USP Grade Clopidogrel (25 kg) API needed in India [ENA20359]
    A company that specializes in manufacturing various finished formulations across various therapeutic areas is looking for suppliers of USP Grade Clopidogrel (25 kg) API for commercial purposes. The suppliers must support this enquiry with CoA.
    26 Aug 2024

    Reply

    26 Aug 2024

    Reply text-arrow

    Reply Comment (7)

    26 Aug 2024

    india-flag.png
    USP Grade Clopidogrel Bisulphate (200 g) API needed in India [ENA20258]
    A company that focuses on development and manufacturing of various oral solid dosage forms, DC granules, pellets, and nutraceuticals is looking for suppliers of USP Grade Clopidogrel Bisulphate (200 g) API for development purposes. The suppliers must support this enquiry with CoA.
    13 Aug 2024

    Reply

    13 Aug 2024

    Reply text-arrow

    Reply Comment (4)

    13 Aug 2024

    Iran.png
    Clopidogrel + Aspirin Pellets needed in Iran [ENA19928]
    A company that focuses on manufacturing and distribution of a various own branded oral antibiotic-related & non-antibiotic products is looking for suppliers of Clopidogrel + Aspirin Pellets for commercial purposes. The suppliers must support this enquiry with CoA.
    11 Jul 2024

    Reply

    11 Jul 2024

    Reply text-arrow

    Reply Comment (4)

    11 Jul 2024

    india-flag.png
    USP Grade Clopidogrel Bisulfate API needed in India [ENA19560]
    A company that focuses on the manufacturing and packaging of various finished formulations, including tablets, capsules, and suppositories, is looking for suppliers of USP Grade Clopidogrel Bisulfate API for commercial purposes. The suppliers must support this enquiry with CoA.
    22 May 2024

    Reply

    22 May 2024

    Reply text-arrow

    Reply Comment (1)

    22 May 2024

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    USP

    read-more
    read-more

    ANALYTICAL

    Upload your methods for free, ask us

    Analytical Methods

    read-more
    read-more

    ABOUT THIS PAGE

    Looking for 135046-48-9 / Clopidogrel API manufacturers, exporters & distributors?

    Clopidogrel manufacturers, exporters & distributors 1

    37

    PharmaCompass offers a list of Clopidogrel API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Clopidogrel manufacturer or Clopidogrel supplier for your needs.

    Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clopidogrel manufacturer or Clopidogrel supplier.

    API | Excipient name

    Clopidogrel

    Synonyms

    120202-66-6, Clopidogrel sulfate, Clopidogrel hydrogen sulfate, Iscover, Plavix, Clopidogrel bisulphate

    Cas Number

    135046-48-9

    Unique Ingredient Identifier (UNII)

    08I79HTP27

    About Clopidogrel

    A ticlopidine analog and platelet purinergic P2Y receptor antagonist that inhibits adenosine diphosphate-mediated PLATELET AGGREGATION. It is used to prevent THROMBOEMBOLISM in patients with ARTERIAL OCCLUSIVE DISEASES; MYOCARDIAL INFARCTION; STROKE; or ATRIAL FIBRILLATION.

    Clopidogrel Bisulfate Manufacturers

    A Clopidogrel Bisulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clopidogrel Bisulfate, including repackagers and relabelers. The FDA regulates Clopidogrel Bisulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clopidogrel Bisulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Clopidogrel Bisulfate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

    Clopidogrel Bisulfate Suppliers

    A Clopidogrel Bisulfate supplier is an individual or a company that provides Clopidogrel Bisulfate active pharmaceutical ingredient (API) or Clopidogrel Bisulfate finished formulations upon request. The Clopidogrel Bisulfate suppliers may include Clopidogrel Bisulfate API manufacturers, exporters, distributors and traders.

    click here to find a list of Clopidogrel Bisulfate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

    Clopidogrel Bisulfate USDMF

    A Clopidogrel Bisulfate DMF (Drug Master File) is a document detailing the whole manufacturing process of Clopidogrel Bisulfate active pharmaceutical ingredient (API) in detail. Different forms of Clopidogrel Bisulfate DMFs exist exist since differing nations have different regulations, such as Clopidogrel Bisulfate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

    A Clopidogrel Bisulfate DMF submitted to regulatory agencies in the US is known as a USDMF. Clopidogrel Bisulfate USDMF includes data on Clopidogrel Bisulfate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Clopidogrel Bisulfate USDMF is kept confidential to protect the manufacturer’s intellectual property.

    click here to find a list of Clopidogrel Bisulfate suppliers with USDMF on PharmaCompass.

    Clopidogrel Bisulfate JDMF

    The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

    The Clopidogrel Bisulfate Drug Master File in Japan (Clopidogrel Bisulfate JDMF) empowers Clopidogrel Bisulfate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

    PMDA reviews the Clopidogrel Bisulfate JDMF during the approval evaluation for pharmaceutical products. At the time of Clopidogrel Bisulfate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

    click here to find a list of Clopidogrel Bisulfate suppliers with JDMF on PharmaCompass.

    Clopidogrel Bisulfate KDMF

    In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

    Pharmaceutical companies submit a Clopidogrel Bisulfate Drug Master File in Korea (Clopidogrel Bisulfate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Clopidogrel Bisulfate. The MFDS reviews the Clopidogrel Bisulfate KDMF as part of the drug registration process and uses the information provided in the Clopidogrel Bisulfate KDMF to evaluate the safety and efficacy of the drug.

    After submitting a Clopidogrel Bisulfate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Clopidogrel Bisulfate API can apply through the Korea Drug Master File (KDMF).

    click here to find a list of Clopidogrel Bisulfate suppliers with KDMF on PharmaCompass.

    Clopidogrel Bisulfate CEP

    A Clopidogrel Bisulfate CEP of the European Pharmacopoeia monograph is often referred to as a Clopidogrel Bisulfate Certificate of Suitability (COS). The purpose of a Clopidogrel Bisulfate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Clopidogrel Bisulfate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Clopidogrel Bisulfate to their clients by showing that a Clopidogrel Bisulfate CEP has been issued for it. The manufacturer submits a Clopidogrel Bisulfate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Clopidogrel Bisulfate CEP holder for the record. Additionally, the data presented in the Clopidogrel Bisulfate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Clopidogrel Bisulfate DMF.

    A Clopidogrel Bisulfate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Clopidogrel Bisulfate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

    click here to find a list of Clopidogrel Bisulfate suppliers with CEP (COS) on PharmaCompass.

    Clopidogrel Bisulfate WC

    A Clopidogrel Bisulfate written confirmation (Clopidogrel Bisulfate WC) is an official document issued by a regulatory agency to a Clopidogrel Bisulfate manufacturer, verifying that the manufacturing facility of a Clopidogrel Bisulfate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Clopidogrel Bisulfate APIs or Clopidogrel Bisulfate finished pharmaceutical products to another nation, regulatory agencies frequently require a Clopidogrel Bisulfate WC (written confirmation) as part of the regulatory process.

    click here to find a list of Clopidogrel Bisulfate suppliers with Written Confirmation (WC) on PharmaCompass.

    Clopidogrel Bisulfate NDC

    National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Clopidogrel Bisulfate as an active pharmaceutical ingredient (API).

    Finished drug products

    The FDA updates the NDC directory daily. The NDC numbers for Clopidogrel Bisulfate API and other APIs are published in this directory by the FDA.

    Unfinished drugs

    The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

    Pharmaceutical companies that manufacture Clopidogrel Bisulfate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

    Compounded drug products

    The NDC directory also contains data on finished compounded human drug products that contain Clopidogrel Bisulfate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Clopidogrel Bisulfate NDC to their finished compounded human drug products, they may choose to do so.

    click here to find a list of Clopidogrel Bisulfate suppliers with NDC on PharmaCompass.

    Clopidogrel Bisulfate GMP

    Clopidogrel Bisulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

    GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

    PharmaCompass offers a list of Clopidogrel Bisulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Clopidogrel Bisulfate GMP manufacturer or Clopidogrel Bisulfate GMP API supplier for your needs.

    Clopidogrel Bisulfate CoA

    A Clopidogrel Bisulfate CoA (Certificate of Analysis) is a formal document that attests to Clopidogrel Bisulfate's compliance with Clopidogrel Bisulfate specifications and serves as a tool for batch-level quality control.

    Clopidogrel Bisulfate CoA mostly includes findings from lab analyses of a specific batch. For each Clopidogrel Bisulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

    Clopidogrel Bisulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (Clopidogrel Bisulfate EP), Clopidogrel Bisulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clopidogrel Bisulfate USP).

    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search